Pfizer Ventures co-led a $123 million series B financing round for Flare Therapeutics, a biotech company working to discover precision medicines for cancer and other diseases.
Read the full post on Becker's Hospital Review - Healthcare News
Pfizer leads $123M financing round for precision medicine company
